Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -11.71MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
Sector
Industry
History
$ 2Close
$ 0.54 - $ 3.91 52-Week Range
Ticker Information
Ticker
PALICompany Name
PALISADE BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPALISADE BIO INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PALI - EBITDA Historical data
| Date | Depreciation, Amortization & Accretion | Earning Before Interest & Taxes (EBIT) | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) |
|---|---|---|---|
| 6/30/2025 | $ 123K | $ -11.83M | $ -11.71M |
| 3/31/2025 | $ 120K | $ -13.13M | $ -13.01M |
| 12/31/2024 | $ 117K | $ -14.43M | $ -14.31M |
| 9/30/2024 | $ 114K | $ -14.07M | $ -13.95M |
| 6/30/2024 | $ 111K | $ -14.18M | $ -14.06M |
| 3/31/2024 | $ 109K | $ -13.49M | $ -13.38M |
| 12/31/2023 | $ 106K | $ -12.3M | $ -12.2M |
| 9/30/2023 | $ 106K | $ -13.04M | $ -12.93M |
| 6/30/2023 | $ 125K | $ -13.43M | $ -13.31M |
| 3/31/2023 | $ 147K | $ -12.38M | $ -12.24M |
Key Performance Insights, Last 5 Years
- PALISADE BIO INC's latest trailing twelve months (TTM) EBITDA stands at $ -13.75M.
- Over the past 5 years, PALISADE BIO INC's average EBITDA has been $ -16.04M.
- The median EBITDA for PALISADE BIO INC during this period was $ -13.57M
- PALISADE BIO INC reached its highest EBITDA over the past 5 years at $ -140K.
- The lowest EBITDA recorded by PALISADE BIO INC in the same timeframe $ -40M
Similar metrics to EBITDA:
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Earning Before Interest & Taxes (EBIT) - [Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].EBIT + DepAmor
(=) EBITDA EBITDA for PALISADE BIO INC is calculated as follows: EBIT [ $ -13.87M ] + DepAmor [ $ 112.64K ]
(=) EBITDA [ $ -13.75M ] PALI - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years
$ -40M
Minimum
Jun 30, 2021
$ -140K
Maximum
Jun 30, 2022
$ -16.04M
Average
$ -13.57M
Median
EBITDA Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
| filtered constituents | 3.24K |
|---|---|
| min | $ -493.3M |
| max | $ 590.6M |
| average | $ 58.9M |
| median | $ 8.92M |
| std | $ 167.01M |